医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma(CHANCE001)

摘要There is considerable potential for integrating transarterial chemoembolization(TACE),programmed death-(ligand)1(PD-[L]1)inhibitors,and molecular targeted treatments(MTT)in hepatocellular carcinoma(HCC).It is necessary to investigate the therapeutic efficacy and safety of TACE combined with PD-(L)1 inhibitors and MTT in real-world situations.In this nationwide,retrospective,cohort study,826 HCC patients receiving either TACE plus PD-(L)1 blockades and MTT(combination group,n=376)or TACE monotherapy(monotherapy group,n=450)were included from January 2018 to May 2021.The primary endpoint was progression-free survival(PFS)according to modified RECIST.The secondary outcomes included overall survival(OS),objective response rate(ORR),and safety.We performed propensity score matching approaches to reduce bias between two groups.After matching,228 pairs were included with a predominantly advanced disease population.Median PFS in combination group was 9.5 months(95%confidence interval[CI],8.4-11.0)versus 8.0 months(95%Cl,6.6-9.5)(adjusted hazard ratio[HR],0.70,P=0.002).OS and ORR were also significantly higher in combination group(median OS,19.2[16.1-27.3]vs.15.7 months[13.0-20.2];adjusted HR,0.63,P=0.001;ORR,60.1%vs.32.0%;P<0.001).Grade 3/4 adverse events were observed at a rate of 15.8%and 7.5%in combination and monotherapy groups,respectively.Our results suggest that TACE plus PD-(L)1 blockades and MTT could significantly improve PFS,OS,and ORR versus TACE monotherapy for Chinese patients with predominantly advanced HCC in real-world practice,with an acceptable safety profile.

更多
广告
作者单位 Center of Interventional Radiology & Vascular Surgery,Department of Radiology,Zhongda Hospital,Medical School,Southeast University,Nanjing 210009,China [1] Department of Minimally invasive Intervention,The Affiliated Cancer Hospital of Zhengzhou University,Zhengzhou 450008,China [2] Department of Interventional Radiology,the Third Affiliated Hospital,Sun Yat-Sen University,Guangzhou 510630,China [3] Department of Interventional Radiology,Union Hospital of Fujian Medical University,Fuzhou 350001,China [4] Department of Interventional Radiology,Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University,Nanjing 210009,China [5] Department of Interventional Radiology,The First Affiliated Hospital of Soochow University,Soochow University,Suzhou 215006,China [6] Hepatobiliary and Pancreatic Interventional Treatment Center,Division of Hepatobiliary and Pancreatic Surgery,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China [7] Department of Interventional Radiology,Eastern Hospital of Hepatobiliary Surgery,Navy Medical University(Second Military Medical University),Shanghai 200438,China [8] Department of Interventional Radiology,Nantong First People's Hospital,Nantong 226001,China [9] Department of Interventional Radiology,Yancheng Third People's Hospital,Yancheng 224008,China [10] Department of Minimally Invasive Interventional Therapy,Sun Yat-Sen University Cancer Center,Guangzhou 510060,China [11] Department of Vascular Surgery,Southwest Hospital,Third Military Medical University(Army Medical University),Chongqing 400038,China [12] Department of Interventional Radiology,Hunan Cancer Hospital,Changsha 410031,China [13] Department of Interventional Oncology,The First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China [14] Department of Interventional Radiology,The Hospital of Nantong University,Nantong 226001,China [15] Department of Interventional Therapy,Shanxi Tumor Hospital,Taiyuan 030001,China [16] Department of Interventional Radiology,Tibet Autonomous Region People's Hospital,Lhasa 850000,China [17] Department of Interventional Radiology,Ganzhou People's Hospital,Ganzhou 341000,China [18] Center of Interventional Oncology and Liver Diseases,Beijing Youan Hospital,Capital Medical University,Beijing 100069,China [19] Department of Interventional Radiology,The Affiliated Wuxi People's Hospital of Nanjing Medical University,Wuxi 214023,China [20] Department of Minimally Invasive Interventional Therapy,Yunnan Tumor Hospital,The Third Affiliated Hospital of Kunming Medical University,Kunming 650118,China [21] Department of Radiology,First Affiliated Hospital of Kunming Medical University,Kunming 650032,China [22] Department of Oncology,The Second Affiliated Hospital of Nanchang University,Nanchang 330006,China [23] Department of Interventional Radiology,Affiliated Hospital of Qingdao University,Qingdao 266000,China [24] Department of Interventional Therapy,Peking University Cancer Hospital and Institute,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Beijing 100142,China [25] Department of Interventional Radiology,Affiliated Cancer Hospital of Shandong First Medical University,Jinan 250117,China [26] interventional Therapy Center,The first Affiliated Hospital of Xinjiang Medical University,Urumqi 830011,China [27] Department of Radiology,Shengjing Hospital of China Medical University,Shenyang 830011,China [28] Department of Interventional Oncology,Tianjin Medical University Cancer Hospital,Tianjin 300060,China [29] Department of Radiology,Tianjin Medical University General Hospital,Tianjin 300052,China [30] Department of Tumor Interventional Therapy,Fujian Cancer Hospital,Fuzhou 350014,China [31] Department of Radiology,The Second Xiangya Hospital,Changsha 410011,China [32] Department of Interventional Radiology,Sichuan Cancer Hospital and Institute,Chengdu 610041,China [33] Department of Interventional Radiology,First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China [34] Department of Hepatobiliary Oncology Surgery,Department of Interventional Oncology,Jiangxi Cancer Hospital of Nanchang University,Nanchang 330029,China [35] Department of Interventional Radiology,The First Hospital of China Medical University,Shenyang 110001,China [36] Department of Radiology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 110001,China [37] Department of Interventional Radiology,General hospital of Ningxia Medical University,Yinchuan 110001,China [38] Department of Interventional Radiology,Guizhou Cancer Hospital,Guiyang 550000,China [39] Department of Interventional Radiology,Fujian Provincial Hospital,Shengli Clinical Medical College of Fujian Medical University,Fuzhou 350001,China [40] Department of Interventional Radiology,Third Affiliated Hospital of Soochow University,Changzhou First Hospital,Changzhou 213004,China [41] Department of Interventional and Vascular Surgery,The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University,Changzhou 213003,China [42] Department of Interventional Therapy,Nantong Tumor Hospital,Nantong 226006,China [43] Department of Interventional Therapy,Jinling Hospital,School of Medicine,Nanjing University,Nanjing 210002,China [44] Department of Interventional Radiology,Affiliated Hospital of Jiangnan University,Wuxi 214122,China [45] Department of Interventional Radiology,The First Affiliated Hospital,and College of Clinical Medicine of Henan University of Science and Technology,Luoyang 471003,China [46] Department of Interventional Radiology and Vascular Surgery,Peking University First Hospital,Beijing 100034,China [47] Department of Interventional Radiology,The Second Hospital of Nanjing,Nanjing 210000,China [48] Department of Oncology and Vascular Intervention,First Hospital of Shanxi Medical University,Taiyuan 030001,China [49] Vascular and Interventional Department,Chongqing University Cancer Hospital,Chongqing 400000,China [50] Department of Interventional Radiology,The Affiliated Hospital of Zunyi Medical College,Zunyi 563000,China [51] Department of Interventional Therapy,The First Hospital of Jilin University,Changchun 130000,China [52] Department of Radiology,The Fourth Hospital of Hebei Medical University,Shijiazhuang,China [53] Department of Interventional Radiology,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China [54] Department of Radiology,Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research,School of Medicine,Lishui Hospital of Zhejiang University,Lishui 323000,China [55] Department of Interventional Radiology,Shanxi Provincial People's Hospital,Taiyuan 030012,China [56] Department of Interventional Medicine,The Second Affiliated Hospital of Zunyi Medical University,Zunyi 563000,China [57] Department of Interventional & Vascular Surgery,The Fourth Hospital of Harbin Medical University,Harbin 150001,China [58] Department of Biostatistics,Nanjing Medical University,Nanjing 211166,China [59] Zhuhai Interventional Medical Center,Zhuhai Precision Medical Center,Zhuhai People's Hospital,Zhuhai Hospital Affiliated with Jinan University,Jinan University,Zhuhai 519000,China [60]
栏目名称
DOI 10.1038/s41392-022-01235-0
发布时间 2024-03-15(万方平台首次上网日期,不代表论文的发表时间)
  • 浏览7
  • 下载0
信号转导与靶向治疗(英文)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷